NSW Minister for Health Ryan Park with PSA NSW Branch President Luke Kelly FPS[/caption]
[post_title] => Pharmacy prescribing trial expands to include skin conditions
[post_excerpt] => With New South Wales recently expanding its pharmacy prescribing trial to include skin conditions, could other jurisdictions soon follow?
[post_status] => publish
[comment_status] => open
[ping_status] => open
[post_password] =>
[post_name] => pharmacy-prescribing-trial-further-expands-into-treatment-for-skin-conditions
[to_ping] =>
[pinged] =>
[post_modified] => 2023-11-29 14:53:01
[post_modified_gmt] => 2023-11-29 03:53:01
[post_content_filtered] =>
[post_parent] => 0
[guid] => https://www.australianpharmacist.com.au/?p=24346
[menu_order] => 0
[post_type] => post
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
)
[title_attribute] => Pharmacy prescribing trial expands to include skin conditions
[title] => Pharmacy prescribing trial expands to include skin conditions
[href] => https://www.australianpharmacist.com.au/pharmacy-prescribing-trial-further-expands-into-treatment-for-skin-conditions/
[module_atts:td_module:private] => Array
(
)
[td_review:protected] => Array
(
)
[is_review:protected] =>
[post_thumb_id:protected] => 24357
)
Crippling adverse effects
Medicine changes
Too much prescribing
Nick Logan MPS[/caption]
Sydney-based community pharmacy Nick Logan Pharmacist Advice supplies clozapine to 70 patients with treatment-resistant schizophrenia. Servicing this ‘disproportionately large’ cohort of patients is due to strong ties with the Assertive Outreach team at nearby Royal North Shore Hospital, says owner Nick Logan MPS.
Mr Logan describes clozapine as a ‘fabulous drug’ that has low extrapyramidal adverse effects, including less akathisia, tremor and little-to-no dystonia or rigidity.
Wherever medicines are used there is a risk of medicine misadventure, said PSA National President Dr Fei Sim FPS.
‘This is about ensuring patients have the support they need to get the most out of their medicines safely and effectively,’ said Dr Sim.
Case scenario
Cassie, a 24-year-old non-pregnant woman, presents to your pharmacy with a prescription for trimethoprim 300 mg, one tablet daily for 7 days. She has not experienced a UTI before.
You invite Cassie into the pharmacy’s private counselling room. You explain that trimethoprim is a common antibiotic used to treat UTIs, but with her permission you would like to discuss with her doctor the treatment duration to ensure it is effective and appropriate. Cassie is very happy for you to call her doctor. You confirm that Cassie is not taking any other medicines, has no other medical conditions, and has no allergies.
Learning objectivesAfter successful completion of this CPD activity, pharmacists should be able to:
Competency standards (2016) addressed: 1.1, 1.4, 1.5, 2.2, 3.1, 3.5 |
Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS.
Introduction
Urinary tract infections (UTIs) are common and seen both in hospitals and the community, particularly in women.1,2 Most have a bacterial cause and affect the bladder (cystitis), but the infection may also affect the kidney(s) (pyelonephritis).1
Diagnosis involves taking a patient history, physical examination, microscopy, culture testing and susceptibility testing. Antibiotic treatment is guided
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.
